| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8485879 | Vaccine | 2018 | 8 Pages |
Abstract
No new or unexpected safety concerns or reporting patterns of 4vHPV with clinically important AEs were detected. Safety profile of 4vHPV is consistent with data from pre-licensure trials and postmarketing safety data.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Jorge E. Arana, Theresa Harrington, Maria Cano, Paige Lewis, Adamma Mba-Jonas, Li Rongxia, Brock Stewart, Lauri E. Markowitz, Tom T. Shimabukuro,